Evidence map›Paper›PMID 29333484›Full record

ArticleThe Lancet. Child & adolescent health2017

Approaching the third decade of paediatric palliative oncology investigation: historical progress and future directions.

Abby R Rosenberg, Joanne Wolfe

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet. Child & adolescent health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Symptom Burden of Children with Cancer and Parental Quality of Life: The Mediating Role of Parental Stress.International journal of environmental research and public health · 2022
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Pediatric Palliative Care in Oncology.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Abby R RosenbergSeattle Children's Hospital Cancer and Blood Disorders Center, Seattle, WA, USA (A R Rosenberg MD); Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA (A R Rosenberg); Treuman Katz Center for Pediatric Bioethics, Seattle Children's Research Institute, Seattle, WA, USA (A R Rosenberg); Department of Psychosocial Oncology and Palliative Care, and Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA, USA (J Wolfe MD); Department of Medicine, Boston Children's Hospital, Boston, MA, USA (J Wolfe); and Harvard Medical School, Boston, MA, USA (J Wolfe).
Joanne WolfeSeattle Children's Hospital Cancer and Blood Disorders Center, Seattle, WA, USA (A R Rosenberg MD); Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA (A R Rosenberg); Treuman Katz Center for Pediatric Bioethics, Seattle Children's Research Institute, Seattle, WA, USA (A R Rosenberg); Department of Psychosocial Oncology and Palliative Care, and Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA, USA (J Wolfe MD); Department of Medicine, Boston Children's Hospital, Boston, MA, USA (J Wolfe); and Harvard Medical School, Boston, MA, USA (J Wolfe).

Funding

NCCIH Supplement to NCATS/CTSA Program for KL2 Scholars - M. SoddersKL2TR002317 · NCATS · UNIVERSITY OF WASHINGTON · PI Christy Michelle McKinney · 2017 to 2026
$14.5M
Institute of Translational Health SciencesKL2TR000421 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$12.6M
NCATS NIH HHS KL2 TR000421NCATS NIH HHS KL2 TR002317NCI NIH HHS L40 CA170049
6 · The paper itself

Abstract

Paediatric palliative care (PPC) endeavours to alleviate the suffering and improve the quality of life of children with serious illnesses and their families. In the past two decades since WHO defined PPC and called for its inclusion in paediatric oncology care, rigorous investigation has provided important insights. For example, the first decade of research focused on end-of-life experiences of the child and the family, underscoring the high prevalence of symptom burden, the barriers to parent-provider concordance with regards to prognosis, as well as the need for bereavement supports. The second decade expanded PPC oncology investigation to include the entire cancer continuum and the voices of patients. Other studies identified the need for support of parents, siblings, and racial and ethnic minority groups. Promising interventions designed to improve outcomes were tested in randomised clinical trials. Future research will build on these findings and pose novel questions about how to continue to reduce the burdens of paediatric cancer.

Identifiers

PMID29333484
PMCPMC5764167

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.